Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study

Erythrodermic psoriasis (EP) is a dermatological emergency and its treatment with secukinumab is still controversial. Furthermore, no data exist regarding the prognostic value of drug abuse in such a condition. We performed a multi-center, international, retrospective study, enrolling a sample of EP...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Med
Main Authors: Damiani, Giovanni, Pacifico, Alessia, Russo, Filomena, Pigatto, Paolo Daniele Maria, Bragazzi, Nicola Luigi, Bonifati, Claudio, Morrone, Aldo, Watad, Abdulla, Adawi, Mohammad
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6617329/
https://ncbi.nlm.nih.gov/pubmed/31159169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8060770
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki